Medlander Medical Technology Inc., a leading Chinese manufacturer of pelvic floor rehabilitation equipment, has completed an initial public offering (IPO) of 25 million shares priced at RMB40.29 on the Shanghai Stock Exchange’s Sci-Tech Innovation Board (STAR). The listing has raised RMB 1 billion (USD148.3 million) for the firm.
Company Background
Founded in 2013, Medlander has established a comprehensive pelvic floor and postpartum rehabilitation ecosystem that covers products, services, education, and data. Its device offerings include electrical stimulation and magnetic stimulation product types.
Financial Performance
In 2021, the company generated RMB342 million (USD50.73 million) in revenues and RMB120 million (USD17.8 million) in net profits.-Fineline Info & Tech
